Abraham Bassan
Principal at Samsara BioCapital
Abraham Bassan is a Principal at Samsara BioCapital, a life science investment firm dedicated to building companies that advance innovative medicines. Prior to joining Samsara, he held operating roles at Revolution Medicines and Bluebird Bio, and before that Mr. Bassan was an Associate at Third Rock Ventures. Abe received an A.B. in Molecular Biology from Princeton University, and an M.S in Developmental Biology from Stanford University. Abe’s oncology cell therapy board roles include CARGO Therapeutics and Link Cell Therapies.